Every year, the British Medical Journal (BMJ) runs a competition to find the cancer care team that has developed new approaches to improve cancer diagnosis and treatment. This year, six teams were shortlisted from across the UK and on the 7th October it was announced that the Oxfordshire-based SCAN pathway had won this year’s award.
- FAQ Items (218)
- Documents (30)
- Links (221)
- Forms (28)
- Research Groups (3)
- Blog posts (5)
- Sections (211)
- MSD Subject Areas (22)
- News Items (1871)
- Units (96)
- Pages (1632)
- Attachments (650)
- MSD Courses (73)
- Teams (13)
- Profiles (1269)
- Events (529)
Poor metabolic health linked to worse brain health
General Research
19 June 2024
People with poor metabolic health are more likely to have memory and thinking problems and worse brain health, according to a new study by researchers at Oxford Population Health. The study is published in Diabetes Care, and is the largest study into metabolic and brain health to date
Members of the Medical Sciences Division recognised in the King’s Birthday Honours 2024
Awards and Appointments General
19 June 2024
Professor Freddie Hamdy, Prof Rajesh Vasantlal Thakker, Prof Claudia Turner, Prof Paul Turner and Prof Rachel Upthegrove have been recognised and celebrated in the 2024 King's Birthday Honours list.
June 2024 - Volunteer Opportunities
18 June 2024
Study demonstrates how AI can develop more personalised cancer treatment strategies
General Research
17 June 2024
University of Oxford researchers have leveraged the power of artificial intelligence (AI) to develop personalised cancer treatments which could be more effective at preventing patient relapse.
New MSD Safety Resource Hub
11 June 2024
Glowing dye helps surgeons eradicate prostate cancer
General Research
11 June 2024
A glowing marker dye that sticks to prostate cancer cells could help surgeons to remove them in real-time, according to a study led by the University of Oxford.
Sildenafil (‘Viagra’) improves brain blood flow and could help to prevent dementia
General Research
10 June 2024
A new trial conducted by the University of Oxford reveals that sildenafil, commonly known as Viagra, enhances blood flow to the brain and improves the function of brain blood vessels in patients at a heightened risk of vascular dementia.
PRINCIPLE and PANORAMIC teams honoured with prestigious Prix Galien Award
Awards and Appointments General
3 June 2024
The teams behind the PRINCIPLE and PANORAMIC clinical trials, run in the Clinical Trials Unit at the Nuffield Department of Primary Care Health Sciences, have been awarded the prestigious Prix Galien Best Public Sector Innovation Award 2024 for their work in conducting innovative, large-scale clinical trials during the COVID-19 pandemic.
New small molecule found to suppress the evolution of antibiotic resistance in bacteria
General Research
28 May 2024
Researchers from the Ineos Oxford Institute for antimicrobial research (IOI) and the Department of Pharmacology at Oxford University, have developed a new small molecule that can suppress the evolution of antibiotic resistance in bacteria and make resistant bacteria more susceptible to antibiotics.
University of Oxford research receives £5 million funding boost from British Heart Foundation
General Research
24 May 2024
Funding will support world-leading cardiovascular disease research.
Hiding in plain sight: study identifies cryptic disease-causing genetic variants not detected by standard testing
General Research
23 May 2024
Researchers in Oxford have identified types of genetic variants that lead to a range of rare disease but are not picked up by standard genetic testing.
Masks work, our comprehensive review has found
General Research
23 May 2024
Safety Network Newsletter issue 8
22 May 2024
Transformative solutions to antibiotic resistance
General Research
21 May 2024
More than 1.2 million people die each year as a direct result of antibiotic-resistant bacterial infections. But this number could soon rise dramatically: as resistance spreads, an increasing number of infections are becoming harder – and sometimes impossible – to treat as antibiotics become less effective.
Academy of Medical Sciences elects eight Oxford researchers as new Fellows
Awards and Appointments General
21 May 2024
The Academy of Medical Sciences has elected eight University of Oxford biomedical and health scientists to its fellowship in 2024.
New Maternity Early Warning Score to be implemented across the NHS
General Research
20 May 2024
Researchers in Oxford have developed a new maternity early warning score that is derived from patient data. The new system, which is being rolled out across the English NHS, will help healthcare providers identify and respond to signs of deterioration in pregnant women
Early blood glucose control for people with type 2 diabetes is crucial for reducing complications and prolonging life
General Research
20 May 2024
Research led by scientists from the Universities of Oxford and Edinburgh has found that early good blood glucose control can minimise the lifetime risk of diabetes-related complications, including heart attacks, kidney failure and vision loss.
Nine Oxford scientists elected as Royal Society Fellows
Awards and Appointments General
17 May 2024
Nine academics from the University of Oxford, including four from the Medical Sciences Division, have joined the Royal Society as Fellows
World hypertension day: How we’re tackling high blood pressure from pregnancy to later life
General Research
17 May 2024
For World Hypertension Day 2024, discover three of our innovative studies – SNAP2, SHIP, and OPTIMISE 2 – aiming to improve blood pressure management across the life cycle through technology and patient involvement.
Cancer Cell study identifies possible ways cancer treatment can lead to harmful side effects
General Research
16 May 2024
Researchers from the Simmons and Koohy Groups in the Weatherall Institute of Molecular Medicine (WIMM) Translational Immune Discovery Unit have identified potential pathways by which cancer treatment can cause colitis.
Load More
